Skip to content

The value and clinical application of ALDH4A1 as a diagnostic marker for erosive carotid atherosclerotic plaques

The value and clinical application of ALDH4A1 as a diagnostic marker for erosive carotid atherosclerotic plaques

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111458
Enrollment
Unknown
Registered
2025-10-31
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic plaques after carotid artery stenosis

Interventions

Stable plaque group:None
Healthy control group:None
Plaque erosion group,:None

Sponsors

Changzhou Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Color Doppler ultrasound and CTA examinations of the neck vessels were used to evaluate the degree of vascular stenosis and the nature of plaques.

Exclusion criteria

Exclusion criteria: Patients with critical conditions such as cognitive dysfunction, other severe organ dysfunction, and multiple complications are excluded.

Design outcomes

Primary

MeasureTime frame
Aldehyde dehydrogenase 4 family, member A1;

Countries

China

Contacts

Public ContactHanyan Xiao

Changzhou Cancer Hospital

8198xhy@163.com+86 13904530893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026